Quick Links

Robert Turcotte, MD, FRCS(C)

Clinical Interest  

Musculoskeletal Oncology

Current Appointments

Maurice E. & Marthe Muller Chair, Division of Orthopaedic Surgery, McGill University
International Professor of the Orthopaedic Research Chair, Department of Orthopaedics, King Khalid University Hospital, Saudi Arabia
Medical Director, Supraregional Sarcoma program
Chairman, Division of Orthopaedic Surgery, McGill University
Associate Professor, Department of Surgery, McGill University
Associate Member, Department of Oncology, McGill University
Staff Orthopaedic Surgeon, McGill University Health Centre 

Medical School

1977-1982    Université de Montréal

Residency

1982-1987    Édouard-Samson Orthopaedic Program, Université de Montréal

Fellowship

1988     Orthopaedic Oncology and Adult Reconstructive Surgery of the Lower Limb, Hôpital Cochin, Paris, France

1988-1989    Orthopaedic Oncology, Mayo Clinic, Rochester, MN

Grants Held in Last 5 Years

Source:
Title:
Applicant:
Amount/Term:

Mach Gaensslen Foundation of Canada
Myxoid Liposarcoma revisited
RE Turcotte, LC Moreau
$3360 / 2010

Source:
Title:
Applicant:
Amount/Term:

Public Health Agency of Canada and Quebec Ministry of Health and Social Affairs
Adverse effects following musculoskeletal allogenic tissue transplantation: a pilot study
RE Turcotte, P Robillard
$96,925 / 2009

Source:
Title:
Applicant:
Amount/Term:

Canadian Institute of Health Research (CIHR) (CTP-79857)
Molecular profiling of breast cancer metastases
P Siegel, RE Turcotte, V Ouellet
$30,000 / 2006-2011

Source:
Title:
Applicant:
Amount/Term:

Mach Gaensslen Foundation of Canada
Outcomes in recurrent soft tissue sarcoma
RE Turcotte, S Abatzoglou
$3360 / 2008

Source:
Title:
Applicant:
Amount/Term:

McGill University Health Centre Research Institute
Outcome in management of long bone metastases
RE Turcotte
$15,000 / 2008-2009

Source:
Title:

Applicant:
Amount/Term:

Howmedica Osteonics Corporation (Stryker Orthopaedics)
An in vivo evaluation of the effect of a hydroxyapatite coating with and without OP-1 on extracortical bone bridging using a canine segmental replacement model    
RE Turcotte
$58,526.52 / 2006-2007

Source:
Title:
Applicant:
Amount/Term:

Canadian Institute of Health Research (CRT-43818)
Interdisciplinary health research team in musculoskeletal neoplasia          
RE Turcotte
$71,000 / 2003-2007

Current Address

McGill University Health Centre 
Montreal General Hospital Site
1650 Cedar Avenue, #B5.159.6
Montreal, QC  H3G 1A4 

Telephone: (514) 934-1934 ext 42266
Fax: (514) 934-8453
robert [dot] turcotte [at] muhc [dot] mcgill [dot] ca

Recent Publications

Evidence for the Role of MMP-13 in Bone Resorption by Giant Cell Tumour of Bone. Mak I. Seidlitz EP. Cowan RW. Turcotte RE. Popovic S. Wu WCH. Singh G. Ghert M. Hum Pathol. 2010 Sep;41(9):1320-9.

High-speed burring with and without the use of chemical or thermal adjuvants in the intralesional management of Giant Cell Tumor of Bone: A systematic review and meta-analysis. H Algawahmed, R Turcotte, F Farrokhyar, M Ghert. (Sarcoma 2010)

Dedifferentiated giant cell tumor of bone in the form of low grade fibroblastic osteogenic sarcoma. A Ajlan, T Alcindor, R Turcotte, A Nahal. Curr Oncol. 2010 Aug;17(4):71-6.         

Local Recurrence After Initial Multidisciplinary Management of Soft Tissue Sarcoma: Is There a Way Out? Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D. Clin Orthop Relat Res. 2010 Nov;468(11):3012-8.

The efficacy of chemical adjuvants on giant-cell tumour of bone: An in vitro study. Gortzak, R. Kandel, B. Deheshi, J. Werier, R. E. Turcotte, P. C. Ferguson, and J. S. Wunder. J Bone Joint Surg Br 2010 92-B: 1475-1479.

Osteogenic Protein-1 Delivered by Hydroxyapatite-coated Implants Improves Bone Ingrowth in Extracortical Bone Bridging. Saran N, Turcotte RE, Zhang R. Clin Orthop Relat Res. 2010 Sep 28. [Epub ahead of print]